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ABSTRACT
Anecdotal reports suggesting that creatine (Cr) supplemen-
tation may cause side effects, such as an increased incidence
of muscle strains or tears, require scientific examination. In
this study, it was hypothesized that the rapid fluid retention
and "dry matter growth" evident after Cr supplementation
may cause an increase in musculotendinous stiffness. Intui-
tively, an increase in musculotendinous stiffness would in-
crease the chance of injury during exercise Twenty men
were randomly allocated to a control or an experimental
group and were examined for-musculotendinous stiffness of
the triceps surae and for numerous performance indices be-
fore and after Cr ingestion. The Cr group achieved a signif-
icant increase in body mass (79.7 ± 10.8 kg vs, 80.9 ± 10.7
kg), counter movement jump height (40.2 ± 4.8 em vs, 42.7
± 5.9 em), and 20-cm drop jump height (32.3 ± 3.3 cm vs,
35.1 ± 4.8 em) after supplementation. No increase was found
for musculotendinous stiffness at any assessment load. There
were no significant changes in any variables within the con-
trol group. These findings have both performance- and in-
jury-related implications. Primarily, anecdotal evidence sug-
gesting that Cr supplementation causes muscular strain in-
juries is not supported by this study. In addition, the in-
crease in jump performance is indicative of performance
enhancement in activities requiring maximal power output.
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Introduction
Numerous research studies have examined the ef-fects of creatine (Cr) supplementation on athletic
performance .and have reported increased strength,
power, and body mass (BM) (10, 23). The 2 proposed
mechanisms for this performance enhancement are (a)
an enhanced storage of phosphocreatine, leading to
improved energy levels that contribute to an enhanced
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force and power output (11, 16, 24) and (b) a more
rapid and efficient recovery period (11, 16, 18).
The performance-enhancing aspects of Cr are well
documented; however, anecdotal reports suggest that
Cr supplementation may cause numerous, harmful
side effects. Susceptibility to renal problems, gastro-
intestinal disturbances, cardiovascular problems, and
an increased risk of soft tissue injury have been the
focus of anecdotal reports, and attention must be paid
to these risks to ensure the safety of this widely used
substance (28). The only proven side effect of Cr sup-
plementation is an increase in BM, with speculation
surrounding other possible side effects. This demon-
strates the distinct need for controlled research in this
area. This study focuses on the issue that Cr may in-
crease the risk of muscular injury.
It has been reported that increased strength is as-
sociated with an increase in the stiffness of the mus-
culotendinous unit (29). This was reportedly due to an
increased activation of cross-bridges. In addition, pre-
vious research has demonstrated an increase in fluid
retention (12, 23) and dry matter growth (14) after Cr
supplementation. Such changes may, in theory, alter
the viscoelastic properties of the series elastic compo-
nent (SEC) of skeletal muscle. The SEC provides the
link between the muscular system and the skeletal sys-
tem; hence, the stiffness of this component determines
numerous performance- and injury-related indices
(39). A relatively stiff musculotendinous unit theoret-
ically predisposes the individual to a greater risk of
injury when compared with a compliant unit (39).
This study hypothesizes that the expected increase
in strength associated with Cr supplementation, when
coupled with the proposed alterations in the stiffness
of SEC after Cr supplementation, may cause a signif-
icant increase in musculotendinous stiffness. Intuitive-
ly, such an adaptation would increase the risk of soft
tissue injury. Because of the paucity of data examining
the effects of Cr on rate of force development (RFD)
and reactive strength, these facets of performance were
examined in this study.
Methods
Experimental Approach to the Problem
By design, this study attempted to quantify any alter-
ations to muscular strength after a Cr-supplementation
program. This research also attempted to quantify any
alterations to SEC of the muscle after Cr supplemen-
tation. An examination of these 2 variables would pro-
vide an insight into the potential injury risks associ-
ated with Cr supplementation. Alterations in measures
of strength, musculotendinous stiffness, RFD, and var-
ious performance measures were assessed before, dur-
ing, and at completion of a standard Cr-supplemen-
tation protocol. The study was a randomized, placebo-
controlled double-blind design. Musculotendinous
stiffness was assessed using methodology previously
implemented and validated (32, 37, 39), and the per-
formance variables assessed reflected powerful, high-
intensity activities. Because of the expected increase in
-ength after Cr supplementation, maximal isometric
-orce was measured on an instrumented calf raise ma-
.iine in addition to maximal RFD. The alterations ev-
idenced in such properties would confirm the uptake
of Cr by the body. Previous research has found a link
between increased musculotendinous stiffness and
muscle strength; hence, the proposed increases in mus-
cle strength associated with a Cr-supplementation pro-
gram were examined in conjunction with musculoten-
dinous stiffness.
Subjects
To investigate the proposed risks and the perfor-
mance-enhancing capabilities of Cr, 22 healthy men
(age, weight, and height were 23.4 ± 4.9 years, 79.4 ±
12.2 kg, and 176.4 ± 7.2 em, respectively) were ex-
amined for musculotendinous stiffness, isometric
force, RFD, counter movement jump (CMJ), and drop
'-llnp (DJ) performance. The Cr group ingested 20
-1 of Cr for 7 days followed by 10 g-d " for 21 days.
mtrol subjects underwent an identical protocol by
mgesting a placebo. The Cr-ingestion protocol was
similar to that of previous research (19) and consisted
of a loading phase and a maintenance phase. Doses
were administered in premeasured vials to ensure ac-
curacy. No exercise was prescribed during the inges-
tion phase, and participants were instructed to main-
tain normal activity levels. Tests were undertaken be-
fore Cr ingestion (pretest), following the 7-day loading
phase (midtest), and at completion of the 28-day in-
gestion period (posttest). The scientists did not imple-
ment a crossover design because the presence of a con-
trol group was deemed to overcome the need for such
a treatment.' The participants completed a prepartici-
pation consent form, and the testing procedures were
approved by the UTS Human Research Ethics Com-
mittee.
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Figure 1. The instrumented calf raise machine used for
musculotendinous stiffness assessment and isometric force
assessment. Knee and ankles angles were maintained at
90°.
Physiological1ests
Body Mass. The BM of each participant was assessed at
each testing session using calibrated electronic scales
(Hycom Equipment, Sydney, Australia) for 2 purposes:
(a) assessment of fluctuations in BM associated with a
Cr-supplementation program and (b) load determina-
tion for participants during assessment of musculoten-
dinous stiffness to ensure that the loads were relative
to BM.
Isometric Force and Rate of Force Development. Assess-
ment of triceps surae strength was performed using a
maximal isometric contraction. The test was per-
formed on an instrumented seated calf raise machine
(Figure 1), with the ankle and knee joints placed in a
neutral (90°)position. The participants were instructed
to exert force as hard and as quickly as possible and
to hold it for 3 seconds. Force data were recorded at
1,000 Hz by a load cell (Chase Engineering, Sydney,
Australia), which was positioned between the ground
and the movable arm of the calf raise machine. From
this data, the maximum force and RFD (5 ms average)
were calculated. Two trials were conducted at each
session, with rest allowed between trials, and the av-
erage of the trials was used. The triceps surae mus-
culature was examined for a number of reasons in-
cluding: (a) the nature of consistent submaximal and
maximal loading this muscle group receives, (b) the
implications for running and jump performance in-
herent in this muscle group, and (c) the relative ease
of isolation of this muscle group. The bar height and
position over the knees were standardized for each
participant. Different lower-leg lengths were taken
into consideration for each participant using a multi-
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link chain in which links could be added and removed
as required.
Musculotendinous Stiffness. Assessment of musculo-
tendinous stiffness was performed using the oscilla-
tion technique (7,32, 39), in a position that was iden-
tical to that used in the isometric force assessment.
This position isolated the triceps surae musculature,
thereby providing the opportunity for examination of
the relationship between musculotendinous stiffness
and force in the triceps surae. The oscillation teclmique
involves the assumption that human muscle is mod-
eled as a damped spring system and that any pertur-
bation to a loaded system will result in oscillations
containing a damping element due to the viscoelastic
properties of the muscle and tendon. The participants
supported a load, that was calculated as a percentage
of BM using the triceps surae musculature, and at-
tempted to maintain a 90° angle at the ankle. A brief
perturbation of the order of 100-200 N was applied,
and the ensuing oscillations were recorded. According
to several authors (32, 37, 39), the system will oscillate
at its natural frequency regardless of the magnitude of
the perturbation.
The oscillations were modeled according to a sec-
ond-order linear equation of the form:
where x is the displacement of the system, g the ac-
celeration due to gravity, and m the mass of the sys-
tem.
Equations were applied to the data to assess the
frequency of oscillations (f), the damping coefficient
(c), the natural frequency of the system (fn), and the
stiffness of the system (k). Various loads were added
to the calf raise machine for assessment. These were
the equivalent of 50, 100, and 200% of BM (SO, 100,
and 200% BM, respectively) at the point of force trans-
mission to the lower leg. For each load, 2 trials were
completed and averaged for each testing session. Rest
periods of 2-3 minutes were allowed between all trials.
A standard warm-up was used at each test occasion
because warm-up has been shown to affect musculo-
tendinous stiffness (26, 39).
Validity and reliability assessment of the instru-
mented calf raise machine were performed before the
research. The reliability of the calf raise machine was
assessed by examination of interday musculotendi-
nous stiffness values. Participants underwent 2 assess-
ment sessions separated by no more than 7 days, in-
volving musculotendinous stiffness assessment at
loads corresponding to SO, 100, and 200% BM. There
were no interday differences as measured by Pearson's
product moment analysis (r = 0.91, P < 0.05). Validity
tests required the participants to perform tests to ex-
amine RFD and the capacity to benefit from a previous
stretch, termed the prestretch augmentation «CM} -
SJ)/SJ X 100), for comparison with the musculoten-
dinous stiffness data. Significant correlations were ev-
ident for both these facets (r = 0.66, P < 0.05; r =
-0.65, p< 0.05, respectively), which are similar to the
results of a previous study (36). The participants were
then divided into a relatively stiff group and a rela-
tively compliant group for assessment of DJ perfor-
mance. The compliant group showed greater perfor-
mance in the DJ 80-cm and the DJ 100-em conditions,
whereas the stiff group exhibited a decrease in per-
formance from these drop heights, which also is in line
with previous research (35).
Statistical Analyses
The sample size for this study was chosen based on
the gain in BM evidenced with Cr supplementation.
The significance of the findings was examined by es-
timating the magnitude of the difference between the
groups using a standardized value or effect size. Effect
size is measured in relation to the principle assessment
criterion; therefore, in this study, because of the pau-
city of data examining Cr and musculotendinous stiff-
ness, the alterations to BM after Cr supplementation
were analyzed to determine effect size. Based on pre-
vious research examining the effect of Cr on BM (10,
24), it was assumed that the effect size for this study
would be quite large (0.74).9). An 80% confidence lev-
el for rejection of the null hypothesis after the supple-
mentation program was desired; hence, power was set
at 0.8 (13 = 1 - 0.2 = 0.8). Therefore, with an effect
size of 0.8 and an alpha level of 0.05, the sample size
of 9 for each group is deemed to be adequate.
A 1-way analysis of variance (ANOVA) was used
to determine differences between the 2 groups at the
pretest in the dependent measures. This test yielded
no differences between the groups before the com-
mencement of the supplementation program. The
posttest data were examined for normality of distri-
bution, and a 2 (group) by 3 (test occasion) ANOVA
with repeated measures on the tests factor was per-
formed on the test data collected on each test occasion.
Follow-up univariate contrasts (Bonferroni) were per-
formed on significant effects to determine the signifi-
cance of the pairwise comparisons or contrasts. A
probability level of 0.05 was adopted for the study.
Two subjects from the Cr group were omitted from
, the results for failure to comply with the supplemen-
tation protocol, reducing the number of participants to
20, with 11 in the control group and 9 in the Cr group.
Results
As shown in Table 1, the Cr group achieved a 1.2-kg
(1.5%) (F = 7.45, P < 0.01) gain in BM at the posttest,
which, in the absence of in vivo measurement and
when compared with the dosages used in previous
research, is indicative of an increase in intramuscular
Creatine Supplementation 29
Table 1. Mean::!: SD for BM and musculotendinous stiffness measures. Creatine group, N = 9, Control group, N = 11.
t BM = body mass.
*Significantly different from pretest value (p < 0.05).
Figure 2. Musculotendinous stiffness at the highest as-
sessment load exhibited a 13% decrease after the creatine-
supplementation program. The control group remained un-
changed (* indicates a pre-post treatment effect, p < 0.05).
PC stores. There were no significant alterations in BM
between the pre- and midtest occasions or between the
OOd- and posttest occasions. Results of repeated mea- .
sures ANOVA showed a significant 13% decrease in
musculotendinous stiffness at the 200% BM load (F =
'":149, P < 0.05) at the posttest (Table 1 and Figure 2).
J changes were evident at submaximal loads of 50
id 100% BM at either the OOd- or the posttest occa-
sions.
Table 2 illustrates the significant 2.5-cm (6.1%) (F
= 4.048, P < 0.05) increase in CMJ height after sup-
plementation and the significant 2.8-cm (8%) (F =
5.569, P < 0.05) increase in DJ performance from 20
em, evident between the pre- and posttest data. There
were no significant alterations in RFD; however, an in-
creasing trend (5%) (F = 1.995, P > 0.05) for isometric
force production was demonstrated. Two additional
increasing trends were evident in the measures of the
40-em and 60-cm DJ performance, 5.5 and 3.7%, re-
spectively. Additional DJ measures of ground contact
time (CT) and height-Cf index showed no significant
alterations. There were no significant changes in any
variables within the control group in the pre- to OOd-
test or the pre- to posttest data.
Discussion
This study showed that BM of the Cr group increased
by 1.2 kg (Table 1). Previous research has shown that
Cr supplementation increases BM in the order of 0.9-
4.8 kg (2, 10, 12, 14, 23). The dosage administered in
this study was similar to that used in previous stud-
ies, with 20 g·d-I being ingested by the participants
for 7 days followed by 10 g·d-I for a further 21 days.
In the absence of direct Cr measurement, it is be-
lieved that the significant gain in mass in the Cr
group after the completion of the 28-day Cr-supple-
mentation period is indicative of significant uptake of
Cr by the body.
The mechanism behind this gain in mass is pres-
ently unknown; however, 2 major factors have
emerged in the literature, namely, water retention and
dry matter growth. The water retention argument has
been supported by research (20) claiming that Cr is an
osmotically active substance and that an alteration in
intracellular Cr quantities may induce cellular swell-
ing. This argument was supported by further research
(21) that showed a decreased urinary output during a
Cr-supplementation program and a resulting increase
in BM that was attributed to an increase in water re-
tention. Conversely, other authors (14, 15) reported
that the. gain in mass was due to dry matter growth
associated with normal water levels in the body. As
such, if the results of this study are interpreted in this
context, the change in BM would not merely be a tran-
sient shift in water volume but would be a hypertro-
phic response of muscle tissue and hence a chronic
rather than an acute response. Further support for
these results (9) has been found in rats, where Cr sup-
plementation causes muscular hypertrophy, thereby
promoting increased strength.
The results of this study further support previous
findings that Cr supplementation increases BM. Ath-
letes desiring a gain in muscle size, strength, and bulk
can use Cr to achieve an increase in BM of the order
of 1-2 kg over relatively short time periods. These re-
Test Group Pretest Midtest Posttest
BMt (kg) Creatine 79.7:!: 10.8 80.5 ::!:10.4 80.9 ::!:10.7*
Control 79.2:!: 13.7 78.8 ::!:13.3 78.5 ::!:13.4
50% BM stiffness (N'm-I) Creatine 3,463.7 ::!:520.9 3,440.1 ::!:470.4 3,403.3 ::!:691.3
Control 3,407.6 ::!:617.2 3,385.0 ::!:651.2 3,311.2 ::!:603.8
100% BM stiffness (N·m-I) Creatine 5,199.7 ::!:789.0 5,275.7 ::!:890.3 4,902.6 ::!:962.6
Control 5,096.1 ::!:973.2 4,978.4 ::!:908.9 5,017.3 ::!:1,089.1
200% BM stiffness (N·m-I) Creatine 8,147.7 ::!:1,652.1 7,469.0 ::!:822.6 7,086.2 ::!:1,055.6*
Control 7,445.8 ::!:1,696.0 7,513.9 :!: 1,805.4 7,227.2 ::!:1,548.6
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*Significantly different from pretest value (p < 0.05).
.sults are indicative of the possibility that Cr may ad-
versely affect endurance performance (27). Endurance
athletes should remain cautious regarding the use of
Cr in a perforrnance-enhancing role.
Musculotendinous stiffness values measured in this
study were within the ranges previously reported by
authors examining stiffness using the oscillation tech-
nique. Previous research revealed considerable varia-
tion, with values ranging from 7.5 kN·m-t to 20
kN·m-t (26, 32, 35, 39). The values reported in this
study are in the lower bracket of these previous find-
ings (Table 1); however, each muscle-tendon unit ex-
hibits different stiffness values depending on the re-
cruitment of motor units during testing, training his-
tory, and amount of warm-up undertaken (13, 26, 37).
A further explanation for the variance shown in these
trials is that numerous techniques have been used to
assess stiffness, with each technique using differing
contraction types and levels, differing joint angles, and
different mathematical models for analysis. Care must
be taken when comparing absolute values among the
literature. The triceps surae musculature was selected
in this study because it is USed regularly, experiences
submaxirnal or maxirnalloading during upright tasks,
may be easily isolated, and consists of both type-I and
type-IT muscle fibers.
This study reported no increase in musculotendi-
nous stiffness at any assessment load (Table 1). It was
hypothesized that an increased intracellular fluid con-
tent resulting from Cr intake would increase the stiff-
ness of the musculotendinous unit, thereby increasing
the risk of injury. However, within the limitations of
this study, the findings clearly show that a 28-day Cr-
supplementation program does not place the individ-
ual in a position.of increased risk of muscle injury as
a' result of an increased stiffness of the musculoten-
dinous unit.
Given the results of this study, it is conceivable that
other factors may be responsible for the anecdotally
reported increased risk of injury. As exercise enhances
the uptake of Cr by the muscles (19, 30), individuals
participating in intense exercise programs while in-
gesting Cr may be placed at a higher risk for injury.
In this study, no exercise was prescribed during the
ingestion period because the authors wanted to isolate
the effect of Cr uptake on risk of injury. Similarly, very
high dosages of Cr also may place the individual at a
greater risk for injury. It has been reported that some
users have a mindset envisaging that if 20 g·d-t of Cr
yields good results then 3 times that amount will have
3 times the effect (6). Another factor that might explain
increased risk of injury with Cr supplementation is
that as BM increases, agonist-antagonist coordination
may be altered causing problems associated with gait
and other movement patterns. Further research is re-
quired to examine this issue.
In this study, the decrease in musculotendinous
stiffness at the 200% BM (Table 1) load may be ex-
plained methodologically. Examination of strength
measures after Cr supplementation showed that
whereas isometric strength was not significantly in-
creased after the Cr-supplementation program, a trend
toward increased force, with a nonsignificant 5% im-
provement, was evident within the Cr group. Numer-
ous research studies have shown an increase in
strength after a Cr-supplementation program (4, 10,
23-25,34). Therefore, it is postulated that the increas-
ing trend in isometric strength was sufficient to affect
the stiffness assessment at the highest load, such that
the load was relatively lighter for the participant as
compared with that in the pretest occasion. This rela-
tively lighter load at the posttest led to a decrease in
the neural drive to the muscle and resulted in de-
creased cross-bridge formation, thereby decreasing the
stiffness of the musculotendinous unit (13).
Based on the results of this study, it is concluded
Table 2. Mean ± SO for performance measures. Creatine group N = 9, Control group N = 11.
Test Group Pretest Midtest Posttest
Counter movement jump (em) Creatine 40.2 ± 4.8 41.4 ± 3.4 42.7 ± 5.9*
Control 39.1 ± 6.0 39.2 ± 7.2 39.5 ± 7.2
Isometric force (N) Creatine 2,908.8 ± 475.3 2,958.5 ± 420.2 3,086.8 ± 625.3
Control 3,037.7 ± 762.5 3,087.1 ± 712.9 3,024.4 ± 632.5
Rate of force development (N·s-I) Creatine 11,677 ± 2,479 11,356 ± 3,332 11,682 ± 3,029
Control 12,646 ± 4,219 12,424 ± 3,854 12,074 ± 3,677
DJ20 height (em) Creatine 32.3 ± 3.3 33.8 ± 3.8 35.1 ± 4.8*
Control 32.8 ± 5.8 33.5 ± 5.9 33.7 ± 7.3
DJ40 height (em) Creatine 34.6 ± 3.2 34.9 ± 3.9 36.5 ± 6.0
Control 34.0 ± 6.3 35.5 ± 7.6 35.5 ± 8.3
DJ60 height (em) Creatine 35.6 ± 4.3 36.3 ± 3.3 36.9 ± 5.9
Control 34.3 ± 7.5 36.1 ± 8.1 35.1 ± 8.7
that mechanical factors related to increased musculo-
tendinous stiffness play no role in increasing the risk
of muscle strain injuries after Cr supplementation.
Given the difficulty in isolating the direct mechanism
of soft tissue injury after a Cr-supplementation pro-
gram, assuming that the mechanism exists, it is pro-
posed that further research be conducted in this area.
Focal points for such a research would include the ac-
tivities leading to the injury and the intramuscular lo-
cation of the injury after a Cr-supplementation pro-
gram. Importantly, the role of exercise during the Cr-
ingestion period must be examined, concentrating on
both uptake of Cr by the body and risk of injury.
Performance tests yielded results similar to those
discussed in previous research. Although isometric
and isotonic muscular contractions rely on different
mechanical properties for force production (38), both
types of contractions have benefited from Cr supple-
mentation. Creatine supplementation has been shown
'-{)improve isometric force production by up to 10%
!, 25) and isotonic strength by up to 26% (4, 12,23,
"4) in subjects who underwent strength training. In
.iUS study, the results of isometric force proved to be
inconsistent with those of previous research, with re-
sults for the Cr group failing to reach statistical sig-
nificance. However, a trend toward increased strength
(5%) was evident, which may have reached signifi-
cance had the participants been prescribed exercise
during the supplementation time. Participation in ex-
ercise during Cr supplementation has been shown to
enhance uptake levels up to a certain level (17, 19). A
previous study has hypothesized that exercise either
promotes blood flow to the active skeletal muscles,
thereby increasing the amount of free Cr available for
absorption by the muscle, or leads to a greater effi-
ciency in the transport kinetics of Cr across the fiber
membrane (19). When examining isometric force, it is
important to note that isometric strength testing by
-~ture is not specific to concentric muscle actions (1).
.2 isoinertial properties of concentric and eccentric
ntractions differ from those of isometric contrac-
nons. Despite this fact, previous research on muscu-
lotendinous stiffness has used this method of testing
(35, 39) because of its practicality and strength mea-
surement at the approximate angle of musculotendi-
nous stiffness.
Rate of force development showed no significant
changes after the Cr-supplementation program (Table
2). The analysis of the results of musculotendinous
stiffness provides an explanation for these findings.
According to Wilson et al. (38), a high RFD is reliant
on a relatively stiff muscle-tendon unit, which permits
greater lengthening of the contractile component of the
muscle as the unit extends. Improved length-tension
and force velocity conditions facilitate rate of produc-
tion of force. Theoretically, a decrease in musculoten-
dinous stiffness would serve to depress the velocity of
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the force that is transmitted between the contractile
component of the muscle and the osteotendinous junc-
tion. No such phenomenon was evident from RFO re-
sults. The results of musculotendinous stiffness were
in agreement with those of RFO, indicating that there
were no alterations in SEC as a result of the Cr-sup-
plementation program.
Counter movement jump performance exhibited a
significant change in the Cr-supplementation pro-
gram. A significant 6.1% (Table 2) increase was evident
on completion of the 28-day ingestion period, which
is in accordance with previous studies (5, 15, 31, 33).
Given that there were no changes in the musculoten-
dinous unit or in isometric strength after Cr supple-
mentation, the mechanism by which CMJ improved
appears to have its origin in the strength gains from
other means, including muscular hypertrophy (9). Pre-
vious research examining the effect of Cr on single
CMJ trials has attributed the gain in performance to
improved power output as a result of increased intra-
muscular PC stores in combination with a training
stimulus (22).
An increase in OJ performance was evident in the
posttest condition, with OJ height from the 20-cmcon-
dition exhibiting a significant 8.7% increase (Table 2).
Interestingly, as was the case in CMJ performance, the
increase in the 20-cm jump height for OJ is evident
despite an increase in BM and no prescribed training.
The instructions for the DJ tests were to minimize
ground CT. This instruction ensured that this test was
a measure of reactive strength in a situation where the
triceps surae musculature was responsible for primary
force production.
The proposed mechanism for this increase in per-
formance was related to the fact that a 20-cm drop
height represents a relatively low eccentric loading
condition, which is an activity that is similar to CMJ;
hence, improvements in this performance measure
may be attributed to the same mechanism that is as-
sumed to improve CMJ. In comparison, under condi-
tions of high eccentric load, e.g., DJ 60 em, perfor-
mance was not significantly improved after Cr sup-
plementation. These results indicate that Cr supple-
mentation does not play a role in improving reactive
strength under conditions of high load, whereas under
conditions of relatively low eccentric loading, there
may be enhancements in performance, e.g., CMJ and
OJ 20 ern. Therefore, activities such as gymnastics floor
routines and high-impact plyometric training regi-
mens may not benefit from a Cr-supplementation pro-
gram because the magnitude of the impulse of landing
and the RFD required for such activities is greater than
the adaptive mechanisms associated with a Cr-supple-
mentation program. This phenomenon has not been
reported in previous literature, and further investiga-
tion is required to determine the performance-enhanc-
ing role of Cr in these situations.
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Practical Applications
The results of this study have numerous injury- and
performance-related implications. An increase in the
tension in SECtheoretically predisposes the individual
to a greater risk of injury during both eccentric and
concentric force production and dissipation situations.
In this study, the stiffness of SEC did not increase
when assessed under identical load conditions. This
study found that a controlled Cr-supplementation pro-
gram does not play a role in the hypothesized in-
creased risk of soft tissue injury. Further supporting
evidence that Cr does not cause an increased risk of
injury is apparent from the performance results. A
CMJ is a relatively slow stretch shorten cycle activity
(>300 ms); hence, optimal performance is achieved
with a relatively compliant musculotendinous system
(38). In this study, performance in this activity in-
creased after supplementation, indicating that there
was no increase in stiffness during the course of the
supplementation program. In addition, there were no
changes to RFD during the course of the supplemen-
tation period. Therefore, if the anecdotal reports of in-
creased risk of muscle strain injury associatedwith Cr
ingestion are true, it would appear that the mechanism
is not a change in the mechanics of the musculoten-
dinous system. Further research is necessary to deter-
mine the validity of such anecdotal reports.
The performance implications stemming from this
research are intriguing. The increase in CMJ and DJ
20 cm was observed after Cr supplementation without
a prescribed exerciseregimen being undertaken. In ad-
dition, these performance enhancements were evident
despite a 1.5% increase in BMafter the supplementa-
tion period. In activities where propulsion from the
ground is required, performance would intuitively de-
Greasewhen there is an increase in the magnitude of
the mass being propelled. In this study, however, the
ergogenic effect of Cr was greater than the increase in
mass, indicating the importance this substance has in
performance of activities requiring high levels of dy-
namic strength and relatively long ground contact
times.
From the perspective of strength gain, this study
showed that isometric strength and RFD did not ex-
hibit a significant increase after Cr supplementation.
Therefore, if the purpose of the Cr-supplementation
program is to increase strength, it should be under-
taken in conjunction with appropriate strength train-
ing for optimal results.
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